RAP charting, page-8388

nice one @RNClarke

picked up a few snippets from BL:

order of next anticipated announcements:

1. 1000 patient australian clinical study results
2. US study results (some 1200 patients / filled all buckets)
3. results will become the basis of FDA submission '... to become the world's first respiratory diagnostic smartphone for respiratory illness ...' (or words v closely to that effect)

to be used by doctors

if get FDA approval ---> '... hope to announce many commercial licensing deals ...' / '... dividends ...' (or words v closely to that effect)

each to their own, buy, hold or sell, but RAP is now at the pointy end of potentially something huge!

there will be plenty of buyers lurking to scoop up any loose stock @ sub 30c, imo